Lijuan Ding

859 total citations
36 papers, 505 citations indexed

About

Lijuan Ding is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Lijuan Ding has authored 36 papers receiving a total of 505 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 12 papers in Oncology and 6 papers in Immunology. Recurrent topics in Lijuan Ding's work include MicroRNA in disease regulation (3 papers), CAR-T cell therapy research (3 papers) and Cancer Diagnosis and Treatment (3 papers). Lijuan Ding is often cited by papers focused on MicroRNA in disease regulation (3 papers), CAR-T cell therapy research (3 papers) and Cancer Diagnosis and Treatment (3 papers). Lijuan Ding collaborates with scholars based in China and Germany. Lijuan Ding's co-authors include Shudong Wang, Honglei Ji, Yang Zheng, Zheng Xu, Quan Liu, Lihua Dong, He Huang, Qiang Wang, Min Liu and Shudong Wang and has published in prestigious journals such as Blood, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Lijuan Ding

33 papers receiving 501 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lijuan Ding China 15 216 147 77 74 61 36 505
Anand Rajan United States 14 228 1.1× 119 0.8× 71 0.9× 125 1.7× 57 0.9× 49 548
Xueying Wang China 8 260 1.2× 212 1.4× 123 1.6× 128 1.7× 95 1.6× 29 683
Serena De Matteis Italy 13 282 1.3× 162 1.1× 119 1.5× 178 2.4× 81 1.3× 34 658
Anna Dąbrowska‐Iwanicka Poland 9 177 0.8× 152 1.0× 74 1.0× 82 1.1× 30 0.5× 26 442
Qiu-Yue Han China 15 220 1.0× 135 0.9× 159 2.1× 85 1.1× 42 0.7× 35 582
Zhuangzhuang Liang China 10 152 0.7× 221 1.5× 108 1.4× 79 1.1× 53 0.9× 23 465
Fortunata Vasaturo Italy 14 252 1.2× 206 1.4× 80 1.0× 67 0.9× 51 0.8× 25 635
Jianping Wang China 17 311 1.4× 164 1.1× 67 0.9× 145 2.0× 105 1.7× 39 661

Countries citing papers authored by Lijuan Ding

Since Specialization
Citations

This map shows the geographic impact of Lijuan Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lijuan Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lijuan Ding more than expected).

Fields of papers citing papers by Lijuan Ding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lijuan Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lijuan Ding. The network helps show where Lijuan Ding may publish in the future.

Co-authorship network of co-authors of Lijuan Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Lijuan Ding. A scholar is included among the top collaborators of Lijuan Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lijuan Ding. Lijuan Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fu, Weijia, et al.. (2025). Piezo1-related physiological and pathological processes in glioblastoma. Frontiers in Cell and Developmental Biology. 13. 1536320–1536320.
2.
Ding, Lijuan, Lin Cui, Yuheng Wang, et al.. (2025). Fructose metabolism in Entner-Doudoroff pathway-deficient Cupriavidus necator H16 depends on the Calvin shunt. Microbiological Research. 298. 128222–128222. 1 indexed citations
3.
Pu, Xiaoyu, Kexin Chen, Lihua Dong, et al.. (2025). FHL2 enhances ITGB1-mediated ECM remodeling and cellular stiffness to promote radioresistance in non-small cell lung cancer. Cell Death Discovery. 11(1). 480–480.
4.
Wang, Yuheng, Lin Cui, Lijuan Ding, et al.. (2024). Unlocking the potential of Cupriavidus necator H16 as a platform for bioproducts production from carbon dioxide. World Journal of Microbiology and Biotechnology. 40(12). 389–389. 7 indexed citations
5.
Wang, Tingting, Lijuan Ding, Huiying Luo, et al.. (2024). Engineering a non-oxidative glycolysis pathway in escherichia coli for high-level citramalate production. Microbial Cell Factories. 23(1). 233–233. 3 indexed citations
6.
7.
8.
9.
Zhao, Guifang, et al.. (2022). microRNA-27a-3p delivered by extracellular vesicles from glioblastoma cells induces M2 macrophage polarization via the EZH1/KDM3A/CTGF axis. Cell Death Discovery. 8(1). 260–260. 18 indexed citations
10.
Ding, Lijuan, Qian Luo, Xiaoqing Li, et al.. (2022). Development and Validation of an Individualized Metabolism-Related Prognostic Model for Adult Acute Myeloid Leukemia Patients. Frontiers in Oncology. 12. 829007–829007. 3 indexed citations
11.
Zhao, Guifang, Lijuan Ding, Hongquan Yu, et al.. (2022). M2-like tumor-associated macrophages transmit exosomal miR-27b-3p and maintain glioblastoma stem-like cell properties. Cell Death Discovery. 8(1). 350–350. 23 indexed citations
12.
Ding, Lijuan, Yongxian Hu, & He Huang. (2021). Novel progresses of chimeric antigen receptor (CAR) T cell therapy in multiple myeloma. PubMed. 8. 1–1. 17 indexed citations
13.
14.
Wang, Qiang, et al.. (2019). <p>The Significance of Adjuvant Therapy for Extrahepatic Cholangiocarcinoma After Surgery</p>. Cancer Management and Research. Volume 11. 10871–10882. 5 indexed citations
15.
Ding, Lijuan, Jiazhen Cui, Yongxian Hu, et al.. (2018). Changes of T Lymphocyte Subsets after CAR-T Cell Therapy and Its Clinical Significance. Blood. 132(Supplement 1). 1423–1423. 2 indexed citations
16.
Ding, Lijuan, et al.. (2016). Tanshinone IIA sensitizes oral squamous cell carcinoma to radiation due to an enhanced autophagy. Environmental Toxicology and Pharmacology. 46. 264–269. 24 indexed citations
17.
Wang, Shudong, Lijuan Ding, Honglei Ji, et al.. (2016). The Role of p38 MAPK in the Development of Diabetic Cardiomyopathy. International Journal of Molecular Sciences. 17(7). 1037–1037. 86 indexed citations
18.
Liu, Min, et al.. (2015). Human immunodeficiency virus-negative plasmablastic lymphoma: A comprehensive analysis of 114 cases. Oncology Reports. 33(4). 1615–1620. 49 indexed citations
19.
Liu, Min, Huidong Wang, Lijuan Ding, et al.. (2015). Dosimetric Comparative Study of 3 Different Postoperative Radiotherapy Techniques (3D-CRT, IMRT, and RapidArc) for II–III Stage Rectal Cancer. Medicine. 94(1). e372–e372. 11 indexed citations
20.
Chang, Pengyu, Yuyu Zhang, Weiyan Shi, et al.. (2015). Therapeutic effects of bone marrow-derived mesenchymal stem cells on radiation-induced lung injury. Oncology Reports. 35(2). 731–738. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anand Rajan Breakdown of academic impact, for papers by Xueying Wang Breakdown of academic impact, for papers by Serena De Matteis Breakdown of academic impact, for papers by Anna Dąbrowska‐Iwanicka Breakdown of academic impact, for papers by Qiu-Yue Han Breakdown of academic impact, for papers by Zhuangzhuang Liang Breakdown of academic impact, for papers by Fortunata Vasaturo Breakdown of academic impact, for papers by Jianping Wang
Rankless by CCL
2026